Stay updated on Psilocybin for Depression/Anxiety in Parkinson's Disease Clinical Trial

Sign up to get notified when there's something new on the Psilocybin for Depression/Anxiety in Parkinson's Disease Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Psilocybin for Depression/Anxiety in Parkinson's Disease Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.
    Difference
    0.1%
    Check dated 2025-04-30T13:56:56.000Z thumbnail image
  3. Check
    16 days ago
    No Change Detected
  4. Check
    23 days ago
    Change Detected
    Summary
    The page has undergone significant content removal regarding a clinical study on the safety and efficacy of risankizumab compared to apremilast for treating moderate plaque psoriasis, including details about the study design, participant criteria, and monitoring methods. The only notable addition is a revision number.
    Difference
    14%
    Check dated 2025-04-16T02:09:29.000Z thumbnail image
  5. Check
    30 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.14.3 to version 2.14.4.
    Difference
    0.1%
    Check dated 2025-04-08T23:36:05.000Z thumbnail image
  6. Check
    37 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.14.2 to version 2.14.3.
    Difference
    0.1%
    Check dated 2025-04-01T18:54:30.000Z thumbnail image
  7. Check
    66 days ago
    Change Detected
    Summary
    The page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.
    Difference
    1%
    Check dated 2025-03-03T22:17:03.000Z thumbnail image
  8. Check
    88 days ago
    Change Detected
    Summary
    The web page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.
    Difference
    1%
    Check dated 2025-02-10T09:35:58.000Z thumbnail image

Stay in the know with updates to Psilocybin for Depression/Anxiety in Parkinson's Disease Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Psilocybin for Depression/Anxiety in Parkinson's Disease Clinical Trial page.